Stay updated on Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial page
- Check5 days agoChange DetectedAn NIH-wide notice about using “Super Intelligence” in place of “Artificial Intelligence” appears above the unavailable study record, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer revision label updates from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe NCT02799901 study page now shows a 403 Forbidden error instead of the study details. The content and navigation are replaced by a generic access-denied screen.SummaryDifference18%

- Check40 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects a deployment/version update rather than a modification to the study information presented.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page no longer lists the MeSH term 'Melanoma' and the 'related topics' section including 'MedlinePlus Genetics', reducing the amount of contextual topic information shown for the study.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page adds Melanoma and MedlinePlus Genetics as related topics and updates the site revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Radiotherapy Combo in Advanced Melanoma Clinical Trial page.